시장보고서
상품코드
1962236

통합 의료 전달 네트워크 시장 분석 및 예측(-2035년) : 유형별, 제품별, 서비스별, 기술별, 컴포넌트별, 용도별, 최종 사용자별, 전개별, 기능별

Integrated Delivery Networks Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, End User, Deployment, Functionality

발행일: | 리서치사: 구분자 Global Insight Services | 페이지 정보: 영문 345 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 통합 의료 전달 네트워크(IDN) 시장은 2024년 250억 달러에서 2034년까지 699억 달러로 확대되며 CAGR 약 10.8%를 나타낼 것으로 예측됩니다. 통합 의료 전달 네트워크(IDN) 시장은 병원, 클리닉 및 의사 간의 협력 서비스를 통해 환자 관리를 효율화하는 의료 시스템을 포함합니다. 이러한 네트워크는 의료 제공 통합을 통해 케어의 질 향상, 환자 결과 개선 및 비용 절감을 목표로 합니다. IDN은 원활한 정보 유통과 환자 관리를 위해 기술을 활용합니다. 의료 수요 증가와 규제 압력은 가치 기반 의료, 상호 운용성, 환자 중심 모델에 중점을 둔 IDN의 성장을 가속하고, 디지털 건강 솔루션 및 협력 케어 프레임워크 이해관계자들에게 수익성 높은 기회를 제공합니다.

통합 의료 전달 네트워크 시장은 연계 의료 서비스와 비용 효과에 중시의 고조를 원동력으로 대폭적인 성장이 전망되고 있습니다. 이 시장 상황에서 서비스 분야는 최고의 성능을 보여 주며 관리 관리 서비스와 가치 기반 의료 모델이 견인 역할을 담당합니다. 이러한 하위 부문은 환자 결과 개선 및 의료비 절감에 매우 중요합니다. 의료 정보 시스템과 원격 의료 솔루션을 포함한 기술 분야가 이에 이어 2위의 성능 분야가 되고 있습니다. 전자건강기록(EHR)과 원격 의료 플랫폼의 도입이 가속화되어 디지털 의료 솔루션으로의 전환을 반영합니다. 예방 의료와 만성 질환 관리를 촉진하는 집단 건강관리 도구도 보급이 진행되고 있습니다. 또한 의료 제공업체와 기술 기업 간의 전략적 제휴는 혁신을 촉진하고 시장 성장을 이끌고 있습니다. 환자 중심의 케어와 맞춤형 의료에 대한 주력은 시장 역학을 계속 형성하고 서비스 제공과 업무 효율 향상을 위한 이해 관계자에게 유리한 성장 기회를 제공합니다.

시장 세분화
유형 급성 의료, 외래 의료, 장기 요양, 재택치료, 재활, 정신건강, 의약품
제품 임상 솔루션, 재무 솔루션, 비즈니스 솔루션
서비스 컨설팅, 구현, 지원 및 유지보수, 훈련 및 교육
기술 원격 의료, 전자건강기록, 인공지능, 블록체인, 클라우드 컴퓨팅, 사물인터넷
구성요소 소프트웨어, 하드웨어, 서비스
용도 환자 관리, 케어 조정, 인구건강관리, 의료 정보 교환
최종 사용자 병원, 클리닉, 외래수술센터(ASC), 진단센터
배포 On-Premise, 클라우드 기반, 하이브리드
기능 데이터 분석, 상호 운용성, 환자 참여, 워크플로우 관리

통합 의료 전달 네트워크(IDN) 시장은 다양한 시장 점유율, 경쟁력 있는 가격 전략, 혁신적인 제품 투입의 급증과 같은 특징을 가지고 있습니다. 각 회사는 전략적 제휴를 활용하여 플랫폼간에 원활하게 통합되는 종합적인 의료 솔루션의 제공에 주력함으로써 시장에서의 지위 강화를 도모하고 있습니다. 이 접근법은 가치 기반 의료에 대한 수요 증가에 대응할 뿐만 아니라 의료 에코시스템의 복잡성을 해결하는 것입니다. 기술 통합과 환자 중심의 케어 솔루션에 중점을 두어 IDN의 구조를 재구성하고 혁신과 효율성을 선호하는 경쟁 환경을 촉진하고 있습니다. 경쟁 벤치마킹의 관점에서 기업들은 경쟁 우위를 얻기 위해 R&D에 많은 투자를 하는 반면, 규제의 영향은 시장 역학 형성에 중요한 역할을 하고 있습니다. 의료 기준 및 데이터 보호법 준수는 시장 진입과 확장 전략 모두에 영향을 미치는 중요한 요소로 계속되고 있습니다. 특히 북미와 유럽의 규제 프레임워크는 엄격한 준수를 요구하고 업무 효율성과 혁신의 진로에 영향을 미치고 있습니다. 기술 진보와 통합형 의료 제공 솔루션으로의 전환을 원동력으로, 시장은 성장의 기운이 높아지고 있습니다.

주요 동향과 촉진요인:

통합 의료 전달 네트워크(IDN) 시장은 몇 가지 주요 동향과 촉진요인에 힘입어 견조한 성장을 이루고 있습니다. 의료 시스템이 환자 결과의 향상과 비용 절감을 동시에 도모하는 중, 가치 기반 의료 중점화가 현저한 동향이 되고 있습니다. 이 전환은 서비스 통합과 협조 케어 모델의 채택을 촉진합니다. 특히 디지털 헬스 솔루션의 기술적 진보도 시장을 견인하고 있습니다. 원격 의료, 전자건강기록, 데이터 분석 등의 혁신 기술은 IDN의 효율성과 효율성을 높입니다. 이러한 기술은 원활한 정보 교환을 가능하게 하고 환자 관리를 개선합니다. 또 다른 촉진요인은 맞춤형 의료에 대한 수요 증가입니다. 환자가 개별적으로 조정된 치료를 추구하는 동안 IDN은 맞춤형 케어 플랜을 제공하기 위해 적응하고 있습니다. 또한, 노화와 만성 질환의 유병률 증가는 종합적이고 통합된 의료 서비스의 필요성을 증가시키고 있습니다. 이 인구 역학의 변화는 IDN이 서비스 제공 범위를 확대하고 서비스 제공을 개선할 수 있는 절호의 기회를 제공합니다. 게다가 의료 인프라 개선을 목적으로 하는 규제면의 지원이나 정부 주도의 대처가 시장을 뒷받침하고 있습니다. 이러한 노력은 의료 접근성과 품질 향상을 약속하는 통합형 제공 모델의 채택을 촉진하고 있습니다. 그 결과, 이러한 강력한 동향과 촉진요인에 힘입어 IDN 시장은 지속적인 성장을 이루려고 합니다.

목차

제1장 주요 요약

제2장 시장 하이라이트

제3장 시장 역학

  • 거시경제 분석
  • 시장 동향
  • 시장 성장 촉진요인
  • 시장 기회
  • 시장 성장 억제요인
  • CAGR : 성장 분석
  • 영향 분석
  • 신흥 시장
  • 기술 로드맵
  • 전략적 프레임워크

제4장 부문 분석

  • 시장 규모 및 예측 : 유형별
    • 급성 의료
    • 외래 의료
    • 장기 요양
    • 재택치료
    • 재활
    • 정신건강
    • 의약품
  • 시장 규모 및 예측 : 제품별
    • 임상 솔루션
    • 금융 솔루션
    • 업무 솔루션
  • 시장 규모 및 예측 : 서비스별
    • 컨설팅
    • 도입
    • 지원 및 유지보수
    • 연수 및 교육
  • 시장 규모 및 예측 : 기술별
    • 원격 의료
    • 전자건강기록
    • 인공지능
    • 블록체인
    • 클라우드 컴퓨팅
    • 사물인터넷(IoT)
  • 시장 규모 및 예측 : 컴포넌트별
    • 소프트웨어
    • 하드웨어
    • 서비스
  • 시장 규모 및 예측 : 용도별
    • 환자 관리
    • 케어 조정
    • 인구건강관리
    • 의료 정보 교환
  • 시장 규모 및 예측 : 최종 사용자별
    • 병원
    • 진료소
    • 외래수술센터(ASC)
    • 진단센터
  • 시장 규모 및 예측 : 전개별
    • On-Premise
    • 클라우드 기반
    • 하이브리드
  • 시장 규모 및 예측 : 기능별
    • 데이터 분석
    • 상호 운용성
    • 환자 참여
    • 워크플로우 관리

제5장 지역별 분석

  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 라틴아메리카
    • 브라질
    • 아르헨티나
    • 기타 라틴아메리카
  • 아시아태평양
    • 중국
    • 인도
    • 한국
    • 일본
    • 호주
    • 대만
    • 기타 아시아태평양
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 스페인
    • 이탈리아
    • 기타 유럽
  • 중동 및 아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 남아프리카
    • 사하라 이남 아프리카
    • 기타 중동 및 아프리카

제6장 시장 전략

  • 수요 및 공급의 갭 분석
  • 무역 및 물류상의 제약
  • 가격, 비용, 마진의 동향
  • 시장 침투
  • 소비자 분석
  • 규제 개요

제7장 경쟁 정보

  • 시장 포지셔닝
  • 시장 점유율
  • 경쟁 벤치마킹
  • 주요 기업의 전략

제8장 기업 프로파일

  • Intermountain Healthcare
  • Geisinger Health
  • Cleveland Clinic
  • Mayo Clinic
  • Kaiser Permanente
  • UPMC
  • Baylor Scott & White Health
  • Advocate Aurora Health
  • Sutter Health
  • Providence St Joseph Health
  • Trinity Health
  • Mercy Health
  • Sentara Healthcare
  • Henry Ford Health System
  • BJC Health Care
  • Spectrum Health
  • Emory Healthcare
  • Novant Health
  • Northwell Health
  • Baptist Health South Florida

제9장 당사에 대해서

JHS

Integrated Delivery Networks Market is anticipated to expand from $25 billion in 2024 to $69.9 billion by 2034, growing at a CAGR of approximately 10.8%. The Integrated Delivery Networks (IDNs) Market encompasses healthcare systems that streamline patient care through coordinated services among hospitals, clinics, and physicians. These networks aim to enhance care quality, improve patient outcomes, and reduce costs by integrating healthcare delivery. IDNs leverage technology for seamless information flow and patient management. Rising healthcare demands and regulatory pressures are propelling IDN growth, with emphasis on value-based care, interoperability, and patient-centric models, thus presenting lucrative opportunities for stakeholders in digital health solutions and collaborative care frameworks.

The Integrated Delivery Networks Market is poised for significant growth, driven by the increasing emphasis on coordinated healthcare services and cost-efficiency. Within this landscape, the service segment emerges as a top performer, with managed care services and value-based care models leading the charge. These sub-segments are pivotal in enhancing patient outcomes and reducing healthcare costs. The technology segment, encompassing health information systems and telehealth solutions, follows as the second highest-performing segment. The adoption of electronic health records and telemedicine platforms is accelerating, reflecting the shift towards digital healthcare solutions. Population health management tools are gaining traction, facilitating preventive care and chronic disease management. Furthermore, strategic partnerships between healthcare providers and technology firms are fostering innovation, driving market growth. The focus on patient-centered care and personalized medicine continues to shape the market dynamics, presenting lucrative opportunities for stakeholders to enhance service delivery and operational efficiency.

Market Segmentation
TypeAcute Care, Outpatient Care, Long-Term Care, Home Health, Rehabilitation, Mental Health, Pharmaceutical
ProductClinical Solutions, Financial Solutions, Operational Solutions
ServicesConsulting, Implementation, Support and Maintenance, Training and Education
TechnologyTelemedicine, Electronic Health Records, Artificial Intelligence, Blockchain, Cloud Computing, Internet of Things
ComponentSoftware, Hardware, Services
ApplicationPatient Management, Care Coordination, Population Health Management, Health Information Exchange
End UserHospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Centers
DeploymentOn-Premise, Cloud-Based, Hybrid
FunctionalityData Analytics, Interoperability, Patient Engagement, Workflow Management

The Integrated Delivery Networks (IDN) market is characterized by a diverse array of market shares, competitive pricing strategies, and a surge in innovative product launches. Companies are leveraging strategic partnerships to enhance their market positioning, focusing on delivering comprehensive healthcare solutions that integrate seamlessly across platforms. This approach not only caters to the growing demand for value-based healthcare but also addresses the complexities of the healthcare ecosystem. The emphasis on technological integration and patient-centric care solutions is reshaping the IDN landscape, fostering a competitive environment that prioritizes innovation and efficiency. In terms of competition benchmarking, major players are investing heavily in R&D to gain a competitive edge, while regulatory influences continue to play a pivotal role in shaping market dynamics. Compliance with healthcare standards and data protection laws remains a critical factor, influencing both market entry and expansion strategies. The regulatory framework, particularly in North America and Europe, demands stringent adherence, impacting operational efficiencies and innovation trajectories. The market is poised for growth, driven by technological advancements and a shift towards integrated healthcare delivery solutions.

Tariff Impact:

The Integrated Delivery Networks (IDN) market is increasingly influenced by global tariffs, geopolitical risks, and evolving supply chain dynamics. Japan and South Korea are adapting to trade tensions by advancing healthcare technology and fostering regional collaborations to mitigate reliance on foreign imports. China's strategy focuses on bolstering domestic healthcare infrastructure and technology, while Taiwan leverages its technological prowess to maintain competitiveness despite geopolitical challenges. The global IDN market is robust, driven by technological advancements and an aging population, with projections indicating significant growth by 2035. However, geopolitical tensions, particularly in the Middle East, pose risks to energy prices and supply chain continuity, necessitating strategic diversification and resilience planning. These dynamics underscore the importance of regional cooperation and innovation in sustaining market evolution.

Geographical Overview:

The Integrated Delivery Networks (IDN) market is witnessing substantial growth across diverse regions, each presenting unique opportunities. North America remains at the forefront, driven by technological advancements and a strong focus on integrated healthcare solutions. The region's robust healthcare infrastructure and emphasis on patient-centered care further propel market growth. Europe follows closely, with significant investments in healthcare integration and digital health initiatives enhancing the market landscape. The Asia Pacific region is emerging as a lucrative growth pocket, fueled by increasing healthcare expenditure and the adoption of integrated healthcare models. Countries such as China and India are leading this expansion, supported by government initiatives and a growing demand for efficient healthcare delivery. Latin America and the Middle East & Africa are also gaining traction as emerging markets. In Latin America, the focus on healthcare reform and modernization is driving IDN adoption, while in the Middle East & Africa, the emphasis on improving healthcare access and quality is fostering market growth.

Key Trends and Drivers:

The Integrated Delivery Networks (IDN) market is experiencing robust growth, propelled by several key trends and drivers. The increasing emphasis on value-based care is a significant trend, as healthcare systems strive to improve patient outcomes while reducing costs. This shift encourages the integration of services and the adoption of coordinated care models. Technological advancements, particularly in digital health solutions, are also driving the market. Innovations such as telehealth, electronic health records, and data analytics are enhancing the efficiency and effectiveness of IDNs. These technologies facilitate seamless information exchange and improve patient management. Another driver is the growing demand for personalized medicine. As patients seek tailored treatments, IDNs are adapting to provide customized care plans. Additionally, the aging population and the rising prevalence of chronic diseases are increasing the need for comprehensive, integrated healthcare services. This demographic shift presents lucrative opportunities for IDNs to expand their reach and improve service delivery. Moreover, regulatory support and government initiatives aimed at improving healthcare infrastructure are bolstering the market. These efforts are encouraging the adoption of integrated delivery models, which promise to enhance healthcare accessibility and quality. As a result, the IDN market is poised for sustained growth, driven by these compelling trends and drivers.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Deployment
  • 2.9 Key Market Highlights by Functionality

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Acute Care
    • 4.1.2 Outpatient Care
    • 4.1.3 Long-Term Care
    • 4.1.4 Home Health
    • 4.1.5 Rehabilitation
    • 4.1.6 Mental Health
    • 4.1.7 Pharmaceutical
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Clinical Solutions
    • 4.2.2 Financial Solutions
    • 4.2.3 Operational Solutions
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Consulting
    • 4.3.2 Implementation
    • 4.3.3 Support and Maintenance
    • 4.3.4 Training and Education
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Telemedicine
    • 4.4.2 Electronic Health Records
    • 4.4.3 Artificial Intelligence
    • 4.4.4 Blockchain
    • 4.4.5 Cloud Computing
    • 4.4.6 Internet of Things
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Software
    • 4.5.2 Hardware
    • 4.5.3 Services
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Patient Management
    • 4.6.2 Care Coordination
    • 4.6.3 Population Health Management
    • 4.6.4 Health Information Exchange
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Hospitals
    • 4.7.2 Clinics
    • 4.7.3 Ambulatory Surgical Centers
    • 4.7.4 Diagnostic Centers
  • 4.8 Market Size & Forecast by Deployment (2020-2035)
    • 4.8.1 On-Premise
    • 4.8.2 Cloud-Based
    • 4.8.3 Hybrid
  • 4.9 Market Size & Forecast by Functionality (2020-2035)
    • 4.9.1 Data Analytics
    • 4.9.2 Interoperability
    • 4.9.3 Patient Engagement
    • 4.9.4 Workflow Management

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 End User
      • 5.2.1.8 Deployment
      • 5.2.1.9 Functionality
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 End User
      • 5.2.2.8 Deployment
      • 5.2.2.9 Functionality
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 End User
      • 5.2.3.8 Deployment
      • 5.2.3.9 Functionality
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 End User
      • 5.3.1.8 Deployment
      • 5.3.1.9 Functionality
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 End User
      • 5.3.2.8 Deployment
      • 5.3.2.9 Functionality
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 End User
      • 5.3.3.8 Deployment
      • 5.3.3.9 Functionality
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 End User
      • 5.4.1.8 Deployment
      • 5.4.1.9 Functionality
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 End User
      • 5.4.2.8 Deployment
      • 5.4.2.9 Functionality
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 End User
      • 5.4.3.8 Deployment
      • 5.4.3.9 Functionality
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 End User
      • 5.4.4.8 Deployment
      • 5.4.4.9 Functionality
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 End User
      • 5.4.5.8 Deployment
      • 5.4.5.9 Functionality
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 End User
      • 5.4.6.8 Deployment
      • 5.4.6.9 Functionality
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 End User
      • 5.4.7.8 Deployment
      • 5.4.7.9 Functionality
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 End User
      • 5.5.1.8 Deployment
      • 5.5.1.9 Functionality
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 End User
      • 5.5.2.8 Deployment
      • 5.5.2.9 Functionality
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 End User
      • 5.5.3.8 Deployment
      • 5.5.3.9 Functionality
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 End User
      • 5.5.4.8 Deployment
      • 5.5.4.9 Functionality
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 End User
      • 5.5.5.8 Deployment
      • 5.5.5.9 Functionality
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 End User
      • 5.5.6.8 Deployment
      • 5.5.6.9 Functionality
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 End User
      • 5.6.1.8 Deployment
      • 5.6.1.9 Functionality
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 End User
      • 5.6.2.8 Deployment
      • 5.6.2.9 Functionality
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 End User
      • 5.6.3.8 Deployment
      • 5.6.3.9 Functionality
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 End User
      • 5.6.4.8 Deployment
      • 5.6.4.9 Functionality
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 End User
      • 5.6.5.8 Deployment
      • 5.6.5.9 Functionality

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Intermountain Healthcare
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Geisinger Health
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Cleveland Clinic
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Mayo Clinic
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Kaiser Permanente
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 UPMC
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Baylor Scott & White Health
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Advocate Aurora Health
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Sutter Health
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Providence St Joseph Health
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Trinity Health
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Mercy Health
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Sentara Healthcare
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Henry Ford Health System
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 BJC Health Care
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Spectrum Health
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Emory Healthcare
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Novant Health
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Northwell Health
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Baptist Health South Florida
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제